期刊
OPEN FORUM INFECTIOUS DISEASES
卷 6, 期 2, 页码 -出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/ofid/ofz028
关键词
dalbavancin; Staphylococcus aureus; substance use
资金
- UW Medicine Patient Safety Innovations Program, University of Washington
We retrospectively evaluated off-label use of dalbavancin as secondary therapy in 32 patients with serious Staphylococcus aureus infections (endocarditis, osteomyelitis, septic thrombophlebitis, epidural infection) who were also persons who use drugs. The majority of patients (56%) had a clinical response to treatment. Only 1 patient who completed the intended dalbavancin course experienced a treatment failure.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据